Cromwell Holdings’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Cromwell Holdings's CRL Position: Q3 2026 in Review
Cromwell Holdings increased its Charles River Laboratories (CRL) stake by 3.8% in Q3 2026, buying an estimated $1.84K and bringing the position to 192 shares worth $56.6K. The position accounts for 0.03% of the portfolio, ranked #457.
Cromwell Holdings first reported a position in CRL in Q2 2024 and has held it in 10 quarters since. 646 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Cromwell Holdings held 192 shares of Charles River Laboratories worth $56.6K as of Q3 2026.
- Cromwell Holdings bought 7 Charles River Laboratories shares in Q3 2026, an estimated $1.84K.
- Charles River Laboratories made up 0.03% of Cromwell Holdings's portfolio in Q3 2026, its #457 holding.
- Cromwell Holdings first reported a position in Charles River Laboratories in Q2 2024 and has held it in 10 quarters since.
- 646 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Cromwell Holdings's 13F filing for Q3 2026, filed 28 Oct 2026.